Literature DB >> 7621510

The application of antisense oligonucleotide technology to the brain: some pitfalls.

B J Chiasson1, J N Armstrong, M L Hooper, P R Murphy, H A Robertson.   

Abstract

1. Amphetamine-induced c-fos and egr-1 expression in the striatum was used as a model in which to study the effects of antisense oligodeoxynucleotides (ODNs) directed at c-fos. Using direct infusions of ODNs into the striata of animals we have demonstrated that c-fos antisense ODNs retain most of their biological activity with 2- or 3-base substitutions. The c-fos antisense and mismatch ODNs attenuated Fos immunoreactivity but had little effect on Egr-1 immunoreactivity. 2. In another group of studies examining the role of c-fos in amygdala kindling, we have demonstrated that ODNs cause neurotoxic damage following repeated daily infusions into the amygdala. The damage observed was greatly diminished when the time interval between infusions was extended.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7621510     DOI: 10.1007/bf02088834

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  31 in total

Review 1.  Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun.

Authors:  J I Morgan; T Curran
Journal:  Annu Rev Neurosci       Date:  1991       Impact factor: 12.449

Review 2.  Antisense oligonucleotide strategies in neuropharmacology.

Authors:  C Wahlestedt
Journal:  Trends Pharmacol Sci       Date:  1994-02       Impact factor: 14.819

3.  Use of excitatory amino acids to make axon-sparing lesions of hypothalamus.

Authors:  J V Nadler; D A Evenson
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

4.  A permanent change in brain function resulting from daily electrical stimulation.

Authors:  G V Goddard; D C McIntyre; C K Leech
Journal:  Exp Neurol       Date:  1969-11       Impact factor: 5.330

5.  D1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour.

Authors:  H A Robertson; M R Peterson; K Murphy; G S Robertson
Journal:  Brain Res       Date:  1989-12-04       Impact factor: 3.252

6.  Oligodeoxynucleoside phosphorothioate stability in subcellular extracts, culture media, sera and cerebrospinal fluid.

Authors:  J M Campbell; T A Bacon; E Wickstrom
Journal:  J Biochem Biophys Methods       Date:  1990-03

7.  Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions.

Authors:  C Wahlestedt; E Golanov; S Yamamoto; F Yee; H Ericson; H Yoo; C E Inturrisi; D J Reis
Journal:  Nature       Date:  1993-05-20       Impact factor: 49.962

8.  Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor.

Authors:  K M Standifer; C C Chien; C Wahlestedt; G P Brown; G W Pasternak
Journal:  Neuron       Date:  1994-04       Impact factor: 17.173

9.  Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.

Authors:  W Y Gao; F S Han; C Storm; W Egan; Y C Cheng
Journal:  Mol Pharmacol       Date:  1992-02       Impact factor: 4.436

Review 10.  Oligodeoxynucleotides as inhibitors of gene expression: a review.

Authors:  C A Stein; J S Cohen
Journal:  Cancer Res       Date:  1988-05-15       Impact factor: 12.701

View more
  7 in total

1.  A1 receptor and adenosinergic homeostatic regulation of sleep-wakefulness: effects of antisense to the A1 receptor in the cholinergic basal forebrain.

Authors:  Mahesh M Thakkar; Stuart Winston; Robert W McCarley
Journal:  J Neurosci       Date:  2003-05-15       Impact factor: 6.167

2.  cAMP response element-binding protein in the amygdala is required for long- but not short-term conditioned taste aversion memory.

Authors:  R Lamprecht; S Hazvi; Y Dudai
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

3.  Suppression of postischemic hippocampal nerve growth factor expression by a c-fos antisense oligodeoxynucleotide.

Authors:  J K Cui; C Y Hsu; P K Liu
Journal:  J Neurosci       Date:  1999-02-15       Impact factor: 6.167

4.  Stimulation of the dorsal periaqueductal gray enhances spontaneous recovery of a conditioned taste aversion.

Authors:  G Andrew Mickley; Kyle D Ketchesin; Linnet Ramos; Joseph R Luchsinger; Morgan M Rogers; Nathanael R Wiles; Nita Hoxha
Journal:  Brain Res       Date:  2012-11-23       Impact factor: 3.252

5.  Antisense-mediated isoform switching of steroid receptor coactivator-1 in the central nucleus of the amygdala of the mouse brain.

Authors:  Ioannis Zalachoras; Gwendolynn Grootaers; Lisa T C M van Weert; Yves Aubert; Suzanne R de Kreij; Nicole A Datson; Willeke M C van Roon-Mom; Annemieke Aartsma-Rus; Onno C Meijer
Journal:  BMC Neurosci       Date:  2013-01-07       Impact factor: 3.288

6.  Antisense-mediated RNA targeting: versatile and expedient genetic manipulation in the brain.

Authors:  Ioannis Zalachoras; Melvin M Evers; Willeke M C van Roon-Mom; Annemieke M Aartsma-Rus; Onno C Meijer
Journal:  Front Mol Neurosci       Date:  2011-07-19       Impact factor: 5.639

Review 7.  Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development.

Authors:  Karishma Dhuri; Clara Bechtold; Elias Quijano; Ha Pham; Anisha Gupta; Ajit Vikram; Raman Bahal
Journal:  J Clin Med       Date:  2020-06-26       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.